| 000 | 01321 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514064840.0 | ||
| 264 | 0 | _c20030711 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diabetes.52.5.1248 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEnglyst, Nicola A | |
| 245 | 0 | 0 |
_aA novel role for CD36 in VLDL-enhanced platelet activation. _h[electronic resource] |
| 260 |
_bDiabetes _cMay 2003 |
||
| 300 |
_a1248-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntigens, CD _xblood |
| 650 | 0 | 4 |
_aCD36 Antigens _xblood |
| 650 | 0 | 4 |
_aCollagen _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLipoproteins, VLDL _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aThromboxane A2 _xblood |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aTaube, Janis M | |
| 700 | 1 | _aAitman, Timothy J | |
| 700 | 1 | _aBaglin, Trevor P | |
| 700 | 1 | _aByrne, Christopher D | |
| 773 | 0 |
_tDiabetes _gvol. 52 _gno. 5 _gp. 1248-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.52.5.1248 _zAvailable from publisher's website |
| 999 |
_c12507608 _d12507608 |
||